EGFR and lung cancer: In conclusion, we provided novel insights that EGFR endocytosis is important for treating lung cancer with wtEGFR in in vitro and in vivo models, suggesting that it is a promising target to improve therapeutic efficacy when its inhibitor and EGFR-TKI are administered together.